J Cancer Prev 2021; 26(4): 266-276
Published online December 30, 2021
https://doi.org/10.15430/JCP.2021.26.4.266
© Korean Society of Cancer Prevention
Kushal Kandhari1 , Sandeep Paudel1
, Komal Raina1,2
, Chapla Agarwal1
, Rama Kant1
, Michael F. Wempe1,3
, Cindy O’Bryant1,3, Rajesh Agarwal1,3
1Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado - Anschutz Medical Campus, Aurora, CO, 2Department of Pharmaceutical Sciences, South Dakota State University, Brookings, SD, 3University of Colorado Cancer Center, University of Colorado - Anschutz Medical Campus, Aurora, CO, USA
Correspondence to :
Rajesh Agarwal, E-mail: Rajesh.Agarwal@cuanschutz.edu, https://orcid.org/0000-0002-9455-0235
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Given the high rates of incidence and mortality associated with pancreatic cancer (PanC), there is a need to develop alternative strategies to target PanC. Recent studies have demonstrated that fruits of bitter melon (
Keywords: Pancreatic neoplasms, Bitter melon, Apoptosis, Angiogenesis, Natural/dietary agents
Gi Dae Kim
Journal of Cancer Prevention 2017; 22(4): 219-227 https://doi.org/10.15430/JCP.2017.22.4.219Young-Min Han, Hye-Rin Ahn, Da-Young Lee, Moon-Young Song, Seung-Won Lee, You-Kyung Jang, Byeong Yeob Jeon, Eun-Hee Kim
J Cancer Prev 2024; 29(4): 165-174 https://doi.org/10.15430/JCP.24.029Muhammad Haroon, Sun Chul Kang
J Cancer Prev 2024; 29(3): 69-87 https://doi.org/10.15430/JCP.24.013